Hereditary systemic immunoglobulin light-chain amyloidosis

Blood

Volumn 125, Issue 21, 2015, Pages 3281-3286

  Benson, Merrill D ^a,b   Liepnieks, Juris J ^a   Kluve Beckerman, Barbara ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; CYTOSINE; GUANINE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CODON; DNA DETERMINATION; FEMALE; GENE MUTATION; HUMAN; KIDNEY AMYLOIDOSIS; KIDNEY FAILURE; KIDNEY PARENCHYMA; MALE; MIDDLE AGED; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SEQUENCE ANALYSIS; AMINO ACID SEQUENCE; DNA MUTATIONAL ANALYSIS; FAMILIAL AMYLOIDOSIS; GENETIC PREDISPOSITION; GENETICS; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PEDIGREE;

AGED; AMINO ACID SEQUENCE; AMYLOIDOSIS, FAMILIAL; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE;

EID: 84983454561     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-12-618108     Document Type: Article

References (16)

1. Gertz MA. Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment. Am J Hematol. 2013; 88(5):416-425.
2. Benson MD. The hereditary amyloidoses. In: Picken MM, Dogan A, Herrera GA, eds. Amyloid and Related Disorders [Surgical Pathology and Clinical Correlations]. New York: Humana Press; 2012:53-67.
3. Picken MM. Amyloidosis-where are we now and where are we heading? Arch Pathol Lab Med. 2010;134(4):545-551.
4. Yazaki M, Liepnieks JJ, Callaghan J, Connolly CE, Benson MD. Chemical characterization of a lambda amyloid protein isolated from formalin-fixed and paraffin-embedded tissue sections. Amyloid. 2004; 11(1):50-55.
5. Liepnieks JJ, Wilson DL, Benson MD. Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis. Amyloid. 2006;13(3):170-177.
6. Nichols WC, Gregg RE, Brewer HB Jr, Benson MD. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics. 1990;8(2):318-323.
7. Linke RP. On typing amyloidosis using immunohistochemistry. Detailled illustrations, review and a note on mass spectrometry. Prog Histochem Cytochem. 2012;47(2):61-132.
8. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of Proteins of Immunological Interest. 5th ed. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1991:647-660.
9. Stevens FJ. Four structural risk factors identify most fibril-forming kappa light chains. Amyloid. 2000;7(3):200-211.
10. Dwulet FE, Strako K, Benson MD. Amino acid sequence of a lambda VI primary (AL) amyloid protein (WLT). Scand J Immunol. 1985;22(6):653-660.
11. Roussel A, Spinelli S, Déret S, Navaza J, Aucouturier P, Cambillau C. The structure of an entire noncovalent immunoglobulin kappa light-chain dimer (Bence-Jones protein) reveals a weak and unusual constant domains association. Eur J Biochem. 1999; 260(1):192-199.
12. Solomon A, Weiss DT, Murphy CL, Hrncic R, Wall JS, Schell M. Light chain-associated amyloid deposits comprised of a novel k constant domain. Proc Natl Acad Sci USA. 1998;95(16):9547-9551.
13. Wally J, Kica G, Zhang Y, et al. Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic kappa1 light chain. Biochim Biophys Acta. 1999;1454(1):49-56.
14. Miliani A, Bergesio F, Salvadori M, et al. Familial AL-amyloidosis in three Italian siblings. Haematologica. 1996;81(2):105-109.
15. Gertz MA, Garton JP, Kyle RA. Primary amyloidosis (AL) in families. Am J Hematol. 1986;22(2):193-198.
16. Enqvist S, Mellqvist U-H, Mölne J, et al. A father and his son with systemic AL amyloidosis. Haematologica. 2009;94(3): 437-439.